Pyrrolotriazine compounds useful as kinase inhibitors and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S183000

Reexamination Certificate

active

07442700

ABSTRACT:
The invention relates to at least one pyrrolotriazine derivative, at least one pharmaceutical composition comprising at least one pyrrolotriazine derivative, and at least one method of using at least one pyrrolotriazine derivative to treat at least one kinase associated condition.

REFERENCES:
patent: 6982265 (2006-01-01), Hunt et al.
patent: 7160883 (2007-01-01), Dyckman et al.
patent: 2006/0084650 (2006-04-01), Dong et al.
patent: WO01/83485 (2001-11-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition, vol. 1, 1004-1010, 1996.
Mass, R. D., Int. J. Radiation Oncology Bio. Phys. vol. 58(3): 932-940, 2004.
'Fabbro et al. Pharmacology & therapeutics 93, 79-98, 2002.
Daifuku Biodrugs 17(3); 169-177, 2003.
Anderson et al., Annu. Rev. Microbiol., 58:183-205, 2004.
Turner et al., Current Pharmaceutical Design. 2, 209-224, 1996.
Sugar et al., Diagn. Microbiol. Infect. Dis. 21: 129-133, 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolotriazine compounds useful as kinase inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolotriazine compounds useful as kinase inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolotriazine compounds useful as kinase inhibitors and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4001301

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.